Category Archives: FAST Company

no menu


COPD affects 10% of the world’s population and is the third leading cause of death. In the U.S., COPD kills one person every four minutes. The economic burden is high: COPD costs nearly $72B a year, 40% spent on ER and hospital stays. Disease exacerbations (acute lung-function deterioration) account for most hospitalizations; half of patients … Continue reading Respiralabs


NeuScience is a therapeutics company leveraging AI and translational biology to target solid tumor cancers. Our drug discovery platform combines panels of patient-derived tumor cells with machine vision and deep learning to find treatments that target aggressive subpopulations at the single-cell level. We have developed a novel method to learn whole-cell phenotypic biomarkers with detection … Continue reading Neuscience

ARIZ Precision Medicine

At ARIZ Precision Medicine, we target epigenetic changes that occur early in cancerization with siRNA-based therapeutics delivered directly to tumor cells. This combination of drug payload and drug delivery system allows for “Dual Targeting” of the cancer cell results in a product that is very safe and potentially curable for the patient.

Argonaut Genomics

Argonaut Genomics is an early stage biopharma focused on developing novel cancer antigens in solid tumors for therapeutic cancer vaccines and cell therapies. We envision a line of precision biologics based on tumor antigens widely shared across patients that can be manufactured as off-the-shelf products for treating and preventing cancer.

CLSI’s FAST International Program Prepares Early-Stage Japanese Companies for JPMorgan

In one of the latest iterations of its expanding FAST International program, CLSI worked with six emerging Japanese life science programs to prepare for first-time appearances at the Biotech Showcase during the annual JP Morgan Conference (JPM) in San Francisco. The technologies presented included therapeutics, a novel drug delivery mechanism and tools to accelerate drug … Continue reading CLSI’s FAST International Program Prepares Early-Stage Japanese Companies for JPMorgan

BioInteractive Technologies

Website BioInteractive Technologies (BIT), endorsed by the Mayo Clinic & Techstars, is a Medical Device and Digital Health company developing intelligent wearables to revolutionize physical therapy for injuries such as Rheumatoid Arthritis, Stroke, Wrist Fractures, Carpal Tunnel Syndrome and Tennis/Golfer’s Elbow; a $12B market in the US alone. BIT’s patent-pending TENZR technology powers a … Continue reading BioInteractive Technologies

Zucero Therapeutics

Organization Address Brisbane Technology Park Suite 1.11, Level 1 1 Westlink Court Darra QLD 4076 Australia Website Zucero Therapeutics is committed to the discovery and development of modified sugar compounds for the treatment of cancer and inflammatory conditions. Zucero’s first clinical candidate is called pixatimod and enhances the ability of the immune system to … Continue reading Zucero Therapeutics


Organization Address 388 Queen St Brisbane, QLD, Australia 4000 Website Microba is an Australian company working to create a community of greater health. Built on leading scientific research, Microba has established itself as a world leader in the analysis of the gut microbiome. With a growing body of global research indicating that the gut … Continue reading Microba

Field Orthopaedics

Organization Address 375 Wickham Tce, Spring Hill, QLD Australia 4000 Website Field Orthopaedics is a medical device company formed from within the orthopaedic community to address the shortcomings in surgical practice. From novel implants to improve surgical reliability, extremity anchors to facilitate soft tissue reconstruction, bone glue to fix small troublesome fractures or drug … Continue reading Field Orthopaedics